U.S.-based PleoPharma announced yesterday that the FDA has granted it a fast-track designation for PP-01, a new ...

Results from a new study published in Clinical and Translational Immunology found that dual-target antibody therapy can enhance cancer-fighting T cells more effectively than current single-target ...

We're learning more about the craving that fuels self-defeating habits—and how new discoveries can help us kick the habit. Addiction hijacks the brain’s neural pathways. Scientists are ...